Literature DB >> 11029345

Tromethamine buffer modifies the depressant effect of permissive hypercapnia on myocardial contractility in patients with acute respiratory distress syndrome.

T Weber1, H Tschernich, C Sitzwohl, R Ullrich, P Germann, M Zimpfer, R N Sladen, G Huemer.   

Abstract

In patients with acute respiratory distress syndrome (ARDS), permissive hypercapnia is a strategy to decrease airway pressures to prevent ventilator-induced lung damage by lowering tidal volumes and tolerating higher arterial carbon dioxide tension. However, in experimental studies hypercapnia impairs myocardial contractility and hemodynamic function. We investigated the effect of short-term permissive hypercapnia on myocardial contractility and hemodynamics in patients with ARDS. We hypothesized that the administration of tromethamine (THAM), a buffer which does not increase carbon dioxide production, would modify these changes. In 12 patients with ARDS, permissive hypercapnia was implemented for 2 h with a target Pa(CO(2))of 80 mm Hg. Patients were randomized to have respiratory acidosis corrected by THAM (pH-corrected group), or not corrected (pH-uncorrected group). Hemodynamic responses were measured, and transesophageal echocardiography (TEE) was used to determine myocardial contractility. Permissive hypercapnia resulted in significant decreases in systemic vascular resistance (SVR) and increases in cardiac output (Q). Myocardial contractility decreased in both groups but significantly less in the pH-corrected group (approximately 10%) than in the pH-uncorrected group (approximately 18%, p < 0.05). Mean arterial pressure decreased and mean pulmonary arterial pressure increased significantly only in the pH-uncorrected group. All values returned to baseline conditions 1 h after permissive hypercapnia was terminated. Our study demonstrates a reversible depression of myocardial contractility and hemodynamic alterations during rapid permissive hypercapnia which were attenuated by buffering with THAM. This may have applicability to the clinical strategy of permissive hypercapnia and allow the benefit of decreased airway pressures to be realized while minimizing the adverse hemodynamic effects of hypercapnic acidosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029345     DOI: 10.1164/ajrccm.162.4.9808092

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  23 in total

Review 1.  Permissive hypercapnia--role in protective lung ventilatory strategies.

Authors:  John G Laffey; Donall O'Croinin; Paul McLoughlin; Brian P Kavanagh
Journal:  Intensive Care Med       Date:  2004-01-14       Impact factor: 17.440

Review 2.  Management of hypercapnia in critically ill mechanically ventilated patients-A narrative review of literature.

Authors:  Ravindranath Tiruvoipati; Sachin Gupta; David Pilcher; Michael Bailey
Journal:  J Intensive Care Soc       Date:  2020-03-30

3.  A CO2 removal system using extracorporeal lung and renal assist device with an acid and alkaline infusion.

Authors:  Nozomi Takahashi; Taka-Aki Nakada; Toshikazu Sakai; Yu Kato; Kazuhiro Moriyama; Osamu Nishida; Shigeto Oda
Journal:  J Artif Organs       Date:  2019-10-04       Impact factor: 1.731

Review 4.  Hypercapnic respiratory acidosis: a protective or harmful strategy for critically ill newborn foals?

Authors:  Modest Vengust
Journal:  Can J Vet Res       Date:  2012-10       Impact factor: 1.310

5.  Liquid extracorporeal carbon dioxide removal: use of THAM (tris-hydroxymethyl aminomethane) coupled to hemofiltration to control hypercapnic acidosis in a porcine model of protective mechanical ventilation.

Authors:  Pablo Tapia; Felipe Lillo; Dagoberto Soto; Leslie Escobar; Felipe Simon; Karina Hernández; Leyla Alegría; Alejandro Bruhn
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

6.  Impact of buffering hypercapnic acidosis on cell wounding in ventilator-injured rat lungs.

Authors:  Sean M Caples; Deborah L Rasmussen; Won Y Lee; Marla Z Wolfert; Rolf D Hubmayr
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-07       Impact factor: 5.464

Review 7.  Mechanical ventilation and the kidney.

Authors:  Jay L Koyner; Patrick T Murray
Journal:  Blood Purif       Date:  2009-11-19       Impact factor: 2.614

8.  Irreversible ischemia of the hand after peripheral administration of tromethamol (THAM).

Authors:  Marjolijn N de Hooge; Bas H Verhoeven; Willem J M J Rutten; Maarten W N Nijsten
Journal:  Intensive Care Med       Date:  2003-01-23       Impact factor: 17.440

9.  Impact of acute hypercapnia and augmented positive end-expiratory pressure on right ventricle function in severe acute respiratory distress syndrome.

Authors:  Armand Mekontso Dessap; Cyril Charron; Jérôme Devaquet; Jérôme Aboab; François Jardin; Laurent Brochard; Antoine Vieillard-Baron
Journal:  Intensive Care Med       Date:  2009-08-04       Impact factor: 17.440

10.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.